Drugs / COLENEURAMIDE
COLENEURAMIDE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00307749 | Mar 2006 → Aug 2007 | diabetic polyneuropathy | Tanabe Pharma Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COLENEURAMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105634 ↗ |
| Known as | Coleneuramida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105634 ↗ |
| Known as | MCC-257 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00307749 ↗ |
| Modality | Small molecule | — CHEMBL2105634 ↗ |